Automatic translation for convenience only — verify medical details in English.

DMD Clinical Trial Statistics

Visual overview of Duchenne muscular dystrophy clinical trials in this catalog — by country, sponsor country, status, therapeutic approach and phase.

Back to trial search

40

Total trials

28

Recruiting trials

25

Countries represented

Clinical trials by country

Number of trials with at least one site in each country. Trials spanning multiple countries are counted once per country.

  • United States26
  • United Kingdom13
  • Spain10
  • Italy10
  • Belgium8
  • Canada8
  • Australia6
  • China4
  • Japan4
  • South Korea4
  • Netherlands4
  • Turkey4
  • Germany3
  • Hong Kong2
  • Jordan2
  • Poland2
  • Taiwan2
  • Belarus1
  • France1
  • Ireland1
  • Israel1
  • New Zealand1
  • Serbia1
  • Russia1
  • Sweden1

A single trial may appear under more than one country if it runs in multiple locations.

Countries Leading DMD Treatment Development

Leadership is earned, not claimed. It's time for more countries to prove they can change the future of Duchenne.

  • United States11
  • China2
  • Japan2
  • Russia1

By study status

Current recruitment and completion status across all catalogued trials.

  • Actively Recruiting20
  • Active, Not Recruiting12
  • Enrolling by Invitation5
  • Not Yet Recruiting3

By clinical trial phase

Trial phase labels as listed in each study record.

  • Phase 212
  • Phase 1/210
  • Phase 35
  • Early Phase 14
  • Phase 13
  • Observational2
  • Phase 42
  • Interventional1
  • Phase 2/31

By therapeutic approach

Trials grouped by standardized therapeutic approach category.

  • Gene Therapy15
  • Exon Skipping14
  • Improving Muscle Growth & Protection8
  • Gene Editing1
  • mRNA / tRNA / saRNA Therapies1
  • Reducing Inflammation1